Ongoing Research and Development
First written in FY2017-Q1. 12 of 37 entries say "Restated". Latest entry: FY2027-H1.
48 other companies' latest entry also says "Other".
- FY2027-H1First-half R&D expense growth; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated interim period were ¥40.799 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated interim period.」
While stating that there had been no material changes in R&D activities, R&D expenses increased from ¥2.470 million in the same period of the previous year to ¥40.799 million. - FY2026Decline in annual R&D expenses; activities continueAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥42.636 million, all of which related to the software business.」
While maintaining its policy of continuing R&D activities, annual R&D expenses were ¥42.636 million, down from ¥49.150 million in the previous fiscal year. - FY2026-H1Significant decline in first-half R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated interim period were ¥2.470 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated interim period.」
While stating that there had been no material changes in R&D activities, first-half R&D expenses were ¥2.470 million, down from ¥36.414 million in the same period of the previous year. - FY2025Decline in annual R&D expenses; activities continueAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥49.150 million, all of which related to the software business.」
Annual R&D expenses were ¥49.150 million, down from ¥96.158 million in the previous fiscal year. The R&D policy covering new technologies, new products and new services continued. - FY2025-H1Decline in first-half R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated interim period were ¥36.414 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated interim period.」
While stating that there had been no material changes in R&D activities, the company reported first-half R&D expenses of ¥36.414 million. - FY2025-Q1RestatedAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥24.282 million, all of which related to the software business. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
The disclosure that there had been no material changes in R&D activities was maintained, and first-quarter R&D expenses of ¥24.282 million were reported. - FY2024Decline in annual R&D expenses; activities continueAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥96.158 million, comprising ¥85.489 million for the software business and ¥10.669 million for the overseas business.」
While maintaining its policy of continuing R&D activities, annual R&D expenses were ¥96.158 million, down from ¥107.762 million in the previous fiscal year. - FY2024-Q3Increase in third-quarter R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the third quarter were ¥75.386 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the third quarter.」
While maintaining the disclosure that there had been no material changes in R&D activities, the company reported R&D expenses of ¥75.386 million for the cumulative period through the third quarter. - FY2024-Q2First-half R&D expense growth; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the second quarter were ¥59.690 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
While stating that there had been no material changes in R&D activities, the company reported first-half R&D expenses of ¥59.690 million. - FY2024-Q1Increase in R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥36.324 million, comprising ¥28.597 million for the software business and ¥7.727 million for the overseas business. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
While maintaining its policy that there have been no material changes in R&D activities, the company disclosed R&D expenses of ¥36.324 million, broken down between the software and overseas businesses. - FY2023Increase in annual R&D expensesAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥107.762 million, comprising ¥92.529 million for the software business and ¥15.233 million for the overseas business.」
Annual R&D expenses were ¥107.762 million, up from ¥41.185 million in the previous fiscal year. - FY2023-Q3Increase in R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the third quarter were ¥72.110 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the third quarter.」
While stating that there had been no material changes in R&D activities, R&D expenses for the cumulative period through the third quarter were ¥72.110 million. - FY2023-Q2Increase in R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the second quarter were ¥41.170 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
While stating that there had been no material changes in R&D activities, R&D expenses were ¥41.170 million, up from ¥8.898 million in the same period of the previous year. - FY2023-Q1RestatedAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥18.257 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
The disclosure states that there have been no material changes in R&D activities and reports first-quarter R&D expenses of ¥18.257 million. - FY2022Decline in annual R&D expensesAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥41.185 million, all of which related to the software business.」
Annual R&D expenses were ¥41.185 million, down from ¥68.064 million in the previous fiscal year. - FY2022-Q3Decline in R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the third quarter were ¥22.754 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the third quarter.」
While maintaining the disclosure that there had been no material changes in R&D activities, R&D expenses for the cumulative period through the third quarter were ¥22.754 million. - FY2022-Q2Decline in R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the second quarter were ¥8.898 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
While stating that there had been no material changes in R&D activities, first-half R&D expenses were ¥8.898 million. - FY2022-Q1Decline in R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥8.637 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
The disclosure states that there have been no material changes in R&D activities, while reporting R&D expenses of ¥8.637 million. - FY2021Decline in annual R&D expensesAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥68.064 million, all of which related to the software business.」
While maintaining its policy of continuing R&D activities, annual R&D expenses were ¥68.064 million, down from ¥90.243 million in the previous fiscal year. - FY2021-Q3Decline in R&D expenses; no change in activitiesAnnual report
「R&D expenses for the cumulative consolidated period through the third quarter were ¥67.315 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period through the third quarter.」
While stating that there had been no material changes in R&D activities, the company reported R&D expenses of ¥67.315 million. - FY2021-Q2Increase in R&D expenses; no change in activitiesAnnual report
「Total R&D expenses for the six-month consolidated period ended [current second quarter] were ¥40,902 thousand. There were no material changes in the status of the Group's R&D activities during the six-month consolidated period ended [current second quarter].」
The disclosure states that there have been no material changes in R&D activities and reports R&D expenses of ¥40.902 million. - FY2021-Q1Decline in R&D expenses; no change in activitiesAnnual report
「Total R&D expenses for the three-month consolidated period ended [current first quarter] were ¥9,596 thousand. There were no material changes in the status of the Group's R&D activities during the three-month consolidated period ended [current first quarter].」
While stating that there were no material changes in R&D activities, the company reported R&D expenses of ¥9,596 thousand. - FY2020Increase in annual R&D expensesAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥90,243 thousand, all of which related to the software business.」
Annual R&D expenses totaling ¥90,243 thousand were disclosed. - FY2020-Q3Increase in R&D expensesAnnual report
「Total R&D expenses for the nine-month consolidated period ended [current third quarter] were ¥83,761 thousand. There were no material changes in the status of the Group's R&D activities during the nine-month consolidated period ended [current third quarter].」
While stating that there were no material changes in R&D activities, the company disclosed R&D expenses of ¥83,761 thousand. - FY2020-Q2Increase in R&D expensesAnnual report
「Total R&D expenses for the six-month period ended [current second quarter] were ¥71,581 thousand. There were no material changes in the status of the Company's R&D activities during the six-month period ended [current second quarter].」
While stating that there were no material changes in R&D activities, the company reported that R&D expenses increased from ¥2,895 thousand in the prior-year period to ¥71,581 thousand. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the three-month period ended [current first quarter] were ¥32,781 thousand. There were no material changes in the status of the Company's R&D activities during the three-month period ended [current first quarter].」
The policy and status indicating no material changes in R&D activities were reiterated, and R&D expenses of ¥32,781 thousand were disclosed. - FY2019RestatedAnnual report
「Technological innovation in internet-related technologies and expanding IoT technologies is advancing rapidly, while industry standards and user needs are also changing quickly. As a result, new technologies, products and services are being introduced one after another. Accordingly, the company is actively working to acquire these new technologies and conduct R&D so that it can provide high-quality new products and services that meet customer needs at low prices.」
The policy of continuing to acquire new technologies and conduct R&D on new products and services was reiterated. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the nine-month period ended [current third quarter] were ¥4,222 thousand. There were no material changes in the status of the Company's R&D activities during the nine-month period ended [current third quarter].」
The statement that there were no material changes in R&D activities was reiterated. - FY2019-Q2Significant decline in R&D expenses; no change in activitiesAnnual report
「Total R&D expenses for the six-month period ended [current second quarter] were ¥2,895 thousand. There were no material changes in the status of the Company's R&D activities during the six-month period ended [current second quarter].」
While stating that there were no material changes in R&D activities, the company reported that R&D expenses decreased from ¥58,514 thousand in the prior-year period to ¥2,895 thousand. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the three-month period ended [current first quarter] were ¥901 thousand. There were no material changes in the status of the Company's R&D activities during the three-month period ended [current first quarter].」
The statement that there were no material changes in R&D activities was reiterated. - FY2018RestatedAnnual report
「Total R&D expenses for the fiscal year were ¥61,409 thousand.」
The company continues to conduct R&D on new technologies, products and services and disclosed annual R&D expenses of ¥61,409 thousand. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the nine-month period ended [current third quarter] were ¥58,959 thousand. There were no material changes in the status of the Company's R&D activities during the nine-month period ended [current third quarter].」
The R&D expenses incurred were disclosed, and the absence of material changes in R&D activities was reiterated. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the six-month period ended [current second quarter] were ¥58,514 thousand. There were no material changes in the status of the Company's R&D activities during the six-month period ended [current second quarter].」
The R&D expenses incurred were disclosed, and the absence of material changes in R&D activities was reiterated. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the three-month period ended [current first quarter] were ¥35,797 thousand. There were no material changes in the status of the Company's R&D activities during the three-month period ended [current first quarter].」
The R&D expenses incurred were disclosed, and the absence of material changes in R&D activities was reiterated. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the nine-month period ended [current third quarter] were ¥86,788 thousand. There were no material changes in the status of the Company's R&D activities during the nine-month period ended [current third quarter].」
The cumulative R&D expenses were disclosed, while the absence of material changes in R&D activities was reiterated. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the six-month period ended [current second quarter] were ¥50,940 thousand. There were no material changes in the status of the Company's R&D activities during the six-month period ended [current second quarter].」
The cumulative R&D expenses were disclosed, and the absence of material changes in R&D activities was reiterated. - FY2017-Q1First statedAnnual report
「Total R&D expenses for the three months ended the first quarter were ¥20.200 million. There were no material changes in the Company’s R&D activities during the period.」
Reports R&D expenses and states that there were no material changes in R&D activities.